On Thursday, Indivior (NASDAQ: INDV), the British drugmaker, cut its 2024 net revenue forecast for the second time in three […]
Indivior (NASDAQ: INDV) Cuts 2024 Revenue Forecast, Stock Plummets Read More »
NEW YORK – U.S. Senator Elizabeth Warren has asked antitrust regulators to scrutinize a $16.5 billion deal in which Novo
US Senator Warren Urges Antitrust Regulators to Investigate Novo Holdings-Catalent Deal Read More »
BERLIN – Switzerland’s COMCO competition commission terminated an investigation against Novartis (NYSE: NVS) into possibly using blocking patents, without consequences,
COMCO Ends Probe into Novartis Patent Practices, Finds No Wrongdoing Read More »
Shares of GSK (NYSE: GSK) rose about 6% on Wednesday after the British drugmaker struck a $2.2 billion settlement over U.S.
GSK (NYSE: GSK) Stock Surges After $2.2 Billion Zantac Lawsuits Settlement Read More »
NEW YORK – CVS Health (NYSE: CVS), UnitedHealth Group (NYSE: UNH), and Cigna (NYSE: CI) have asked U.S. Federal Trade
CVS, UnitedHealth, and Cigna Ask FTC Chair to Disqualify Herself from Insulin Case Read More »
The European Commission authorized Novavax’s (NASDAQ: NVAX) updated COVID-19 vaccine targeting the JN.1 strain of coronavirus in the region, the
FRANKFURT – Fresenius (NYSE: FMS) said it was checking options to speed up the start of new production lines of
Fresenius (NYSE: FMS) Looking to Boost Output After Hurricane Damage at Rival Baxter Read More »
LONDON – On Tuesday, Pfizer (NYSE: PFE) and its German partner BioNTech (NASDAQ: BNTX) won their attempt to invalidate two
Pfizer and BioNTech Win Bid to Invalidate CureVac’s UK COVID Vaccine Patents Read More »
U.S. sales of RSV vaccines from GSK (NYSE: GSK) and Pfizer (NYSE: PFE) are down significantly after regulators narrowed the
Pfizer and GSK RSV Vaccine Sales Fall in US as Millions Fewer People Line Up Read More »
On Monday, a drug compounding industry group sued the U.S. Food and Drug Administration over its decision to take Eli
Compounding Group Sues FDA Over Removal of Lilly’s Weight Loss Drug from Shortage List Read More »
LONDON – On Monday, Pfizer (NYSE: PFE) won a bid in a London court to invalidate two of GSK’s (NYSE:
Pfizer Secures Legal Victory Against GSK in RSV Vaccine Patent Dispute Read More »
On Monday, AstraZeneca (NASDAQ: AZN) said it would pay up to $1.92 billion to CSPC Pharmaceutical Group Ltd in an
The U.S. Food and Drug Administration has placed a clinical hold on Kezar Life Sciences’ (NASDAQ: KZR) trial of an
Kezar Life Sciences (NASDAQ: KZR) Faces Setback as US FDA Puts Lupus Drug Trial on Hold Read More »
GSK (NYSE: GSK), Sanofi (NASDAQ: SNY), and CSL Ltd have secured $72 million from the U.S. government to ramp up
Sanofi, GSK, CSL Secure $72 Million Funding to Expand US Bird Flu Vaccine Supply Read More »
SAO PAULO – Novo Nordisk (NYSE: NVO), a Danish drugmaker, will invest 864 million reais ($158.2 million) to revamp a
Novo Nordisk (NYSE: NVO) to Invest $158 Million in Upgrading Insulin Plant in Brazil Read More »
One of the largest contract drug manufacturing plants in the U.S. owned by Thermo Fisher Scientific (NYSE: TMO) over the
Thermo Fisher’s Plant Making Infant RSV Drug Breached FDA Rules, Documents Show Read More »
On Friday, Recordati, the Italian pharma group, said it would buy from Sanofi (NASDAQ: SNY) the global rights to a
Recordati and Sanofi Shares Rise Following $825 Million Drug Rights Deal Read More »
Humana (NYSE: HUM) shares fell as much as 22.4% on Wednesday, as the health insurer said enrollments in its top-rated
On Tuesday, Novo Nordisk (NYSE: NVO), a Danish drugmaker, said it has mitigation plans in place to minimize or prevent
Novo Nordisk (NYSE: NVO) Unveils Plans to Mitigate Disruption from Port Strikes Read More »
Health insurers Cigna (NYSE: CI), CVS Health (NYSE: CVS), Humana (NYSE: HUM), and Centene (NYSE: CNC) on Tuesday released details
Health Insurers Unveil Medicare Advantage Plans for 2025 Read More »
NEW YORK – CVS Health (NYSE: CVS) is exploring options that could include a break-up of the company to separate
CVS Health (NYSE: CVS) Explores Options Including Potential Break-Up: Reuters Read More »
Pfizer (NYSE: PFE) sold a stake in British consumer healthcare group Haleon (NYSE: HLN) worth about $3.26 billion on Monday,
Pfizer (NYSE: PFE) Cuts Haleon Stake to 15%, Selling $3.3 Billion in Shares Read More »
On Monday, Bristol Myers Squibb (NYSE: BMY) won the dismissal of a $6.4 billion lawsuit claiming it cheated former Celgene
Bristol Myers Wins Dismissal of $6.4 Billion Lawsuit Over Celgene Drug Approval Delays Read More »
A Missouri mother and her lawyers this week will aim to convince a jury that Abbott (NYSE: ABT), Reckitt’s Mead
Abbott and Reckitt Face Trial Over Premature Baby Formula Amid Alarm From Doctors Read More »
Copyright © 2025 abbonews.com
